Completed
Study Of Treximet, Formerly Known as Trexima, In The Acute Treatment Of Multiple Migraine Attacks
NCT00240617
- Conditions
- Behavior, Brain Diseases, Central Nervous System Diseases, +5 more
- Locations
-
- GSK Investigational Site Anniston, Alabama, United States
- GSK Investigational Site Tuscaloosa, Alabama, United States
- GSK Investigational Site Mesa, Arizona, United States
- GSK Investigational Site Phoenix, Arizona, United States